A spokesperson for the Advanced Medical Technology Association (AdvaMed) said the device-tax repeal bill cleared by the House Tuesday is just two votes shy of Senate passage and held up multiple reasons he and AdvaMed President and CEO Scott Whitaker are confident it will move through the upper chamber this year. Greg Crist, AdvaMed’s executive vice president for public affairs, noted the Senate version, Sen. Orrin Hatch (R-UT)’s Medical Device Access and Innovation Protection Act, already has eight Democratic cosponsors;...